Year |
Citation |
Score |
2022 |
Xiao Z, Alam IS, Simonetta F, Chen W, Scheller L, Murty S, Lohmeyer JK, Lopes Ramos TL, James ML, Negrin RS, Gambhir SS. ICOS ImmunoPET Enables Visualization of Activated T Cells and Early Diagnosis of Murine Acute Gastrointestinal GvHD. Blood Advances. PMID 35790103 DOI: 10.1182/bloodadvances.2022007403 |
0.789 |
|
2022 |
Xie J, El Rami F, Zhou K, Simonetta F, Chen Z, Zheng X, Chen M, Balakrishnan PB, Dai SY, Murty S, Alam IS, Baker J, Negrin RS, Gambhir SS, Rao J. Multiparameter Longitudinal Imaging of Immune Cell Activity in Chimeric Antigen Receptor T Cell and Checkpoint Blockade Therapies. Acs Central Science. 8: 590-602. PMID 35647285 DOI: 10.1021/acscentsci.2c00142 |
0.777 |
|
2021 |
Beinat C, Patel CB, Haywood T, Murty S, Naya L, Castillo JB, Reyes ST, Phillips M, Buccino P, Shen B, Park JH, Koran ME, Alam IS, James ML, Holley D, et al. A Clinical PET Imaging Tracer ([F]DASA-23) to Monitor Pyruvate Kinase M2 Induced Glycolytic Reprogramming in Glioblastoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34475101 DOI: 10.1158/1078-0432.CCR-21-0544 |
0.77 |
|
2020 |
Murty S, Labanieh L, Murty T, Gowrishankar G, Haywood T, Alam IS, Beinat C, Robinson E, Aalipour A, Klysz DD, Cochran JR, Majzner RG, Mackall CL, Gambhir SS. PET reporter gene imaging and ganciclovir-mediated ablation of chimeric antigen receptor T-cells in solid tumors. Cancer Research. PMID 32958548 DOI: 10.1158/0008-5472.Can-19-3579 |
0.806 |
|
2020 |
Murty S, Haile ST, Beinat C, Aalipour A, Alam IS, Murty T, Shaffer TM, Patel CB, Graves EE, Mackall CL, Gambhir SS. Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model. Oncoimmunology. 9: 1757360. PMID 32923113 DOI: 10.1080/2162402X.2020.1757360 |
0.787 |
|
2020 |
Alam IS, Simonetta F, Scheller L, Mayer AT, Murty S, Vermesh O, Nobashi TW, Lohmeyer JK, Hirai T, Baker J, Lau KH, Negrin R, Gambhir SS. Visualization of activated T cells by OX40-immunoPET as a strategy for diagnosis of acute Graft-versus-Host-Disease. Cancer Research. PMID 32900772 DOI: 10.1158/0008-5472.Can-20-1149 |
0.773 |
|
2020 |
Aalipour A, Le Boeuf F, Tang M, Murty S, Simonetta F, Lozano AX, Shaffer TM, Bell JC, Gambhir SS. Viral Delivery of CAR Targets to Solid Tumors Enables Effective Cell Therapy. Molecular Therapy Oncolytics. 17: 232-240. PMID 32346612 DOI: 10.1016/J.Omto.2020.03.018 |
0.782 |
|
2020 |
Theruvath J, Smith B, Linde MH, Sotillo E, Heitzeneder S, Marjon K, Tousley A, Lattin J, Banuelos A, Dhingra S, Murty S, Mackall CL, Majzner RG. Abstract PR07: GD2 is a macrophage checkpoint molecule and combined GD2/CD47 blockade results in synergistic effects and tumor clearance in xenograft models of neuroblastoma and osteosarcoma Cancer Research. 80. DOI: 10.1158/1538-7445.Pedca19-Pr07 |
0.392 |
|
2020 |
Murty S, Haile ST, Beinat C, Aalipour A, Alam IS, Murty T, Shaffer TM, Patel CB, Graves EE, Mackall CL, Gambhir SS. Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model Oncoimmunology. 9: 1757360. DOI: 10.1080/2162402x.2020.1757360 |
0.706 |
|
2019 |
Haywood T, Beinat C, Gowrishankar G, Patel CB, Alam IS, Murty S, Gambhir SS. Positron emission tomography reporter gene strategy for use in the central nervous system. Proceedings of the National Academy of Sciences of the United States of America. PMID 31123153 DOI: 10.1073/Pnas.1901645116 |
0.758 |
|
2019 |
Aalipour A, Chuang HY, Murty S, D'Souza AL, Park SM, Gulati GS, Patel CB, Beinat C, Simonetta F, Martinić I, Gowrishankar G, Robinson ER, Aalipour E, Zhian Z, Gambhir SS. Engineered immune cells as highly sensitive cancer diagnostics. Nature Biotechnology. PMID 30886438 DOI: 10.1038/S41587-019-0064-8 |
0.749 |
|
2019 |
Patel C, Beinat C, Haywood T, Murty S, Xie Y, Recht L, Nagpal S, Thomas R, Khalighi M, Gandhi H, Holley D, Gambhir S. NIMG-36. EVALUATION OF [18F]DASA-23 FOR NON-INVASIVE MEASUREMENT OF ABERRANTLY EXPRESSED PYRUVATE KINASE M2 IN GLIOMA: FIRST-IN-HUMAN STUDY Neuro-Oncology. 21: vi169-vi169. DOI: 10.1093/Neuonc/Noz175.706 |
0.523 |
|
2019 |
Simonetta F, Alam IS, Mayer AT, Murty S, Vermesh O, Hirai T, Nobashi T, Lau K, Gambhir SS, Negrin RS. Tracking T Cell Activation By OX40 ImmunoPET: A Novel Strategy for Imaging of Graft Versus Host Disease Biology of Blood and Marrow Transplantation. 25: S300. DOI: 10.1016/J.Bbmt.2018.12.680 |
0.793 |
|
2018 |
Beinat C, Haywood T, Chen YS, Patel CB, Alam IS, Murty S, Gambhir SS. The Utility of [F]DASA-23 for Molecular Imaging of Prostate Cancer with Positron Emission Tomography. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. PMID 29736561 DOI: 10.1007/S11307-018-1194-Y |
0.771 |
|
2018 |
Simonetta F, Alam IS, Mayer AT, Murty S, Vermesh O, Hirai T, Nobashi T, Lau K, Gambhir SS, Negrin RS. Tracking T Cell Activation By OX40 Immuno-PET: A Novel Strategy for Imaging of Graft Versus Host Disease Blood. 132: 4527-4527. DOI: 10.1182/blood-2018-99-116483 |
0.419 |
|
2018 |
Beinat C, Patel C, Murty S, Haywood T, Hyung Park J, Xie Y, Gambhir S. CBMT-08. COMPARISON OF THREE METABOLIC PET RADIOTRACERS IN GLIOBLASTOMA: CELL CULTURE AND ANIMAL STUDIES Neuro-Oncology. 20: vi34-vi34. DOI: 10.1093/Neuonc/Noy148.127 |
0.503 |
|
2018 |
Patel C, Beinat C, Xie Y, Haywood T, Murty S, Chang E, Gambhir S. CBMT-03. A NOVEL METABOLIC PET TRACER STRATEGY TO DETERMINE EARLY EFFECTS OF TUMOR TREATING FIELDS (TTFIELDS) Neuro-Oncology. 20: vi32-vi33. DOI: 10.1093/Neuonc/Noy148.122 |
0.53 |
|
2017 |
Aalipour A, Dudley JC, Park SM, Murty S, Chabon JJ, Boyle EA, Diehn M, Gambhir SS. Deactivated CRISPR Associated Protein 9 for Minor-Allele Enrichment in Cell-Free DNA. Clinical Chemistry. PMID 29038154 DOI: 10.1373/Clinchem.2017.278911 |
0.722 |
|
2017 |
Johnson E, Murty S, Mayer A, Tsai C, Mehta S, Ilovich O, Massoud T, Andreasson K, James M. TMIC-30. TREM1-TARGETED PET IMAGING OF TUMOR-ASSOCIATED MACROPHAGES IN AN ORTHOTOPIC GLIOBLASTOMA MOUSE MODEL Neuro-Oncology. 19: vi249-vi249. DOI: 10.1093/Neuonc/Nox168.1019 |
0.76 |
|
2016 |
Sun L, Joh DY, Al-Zaki A, Stangl M, Murty S, Davis JJ, Baumann BC, Alonso-Basanta M, Kaol GD, Tsourkas A, Dorsey JF. Theranostic Application of Mixed Gold and Superparamagnetic Iron Oxide Nanoparticle Micelles in Glioblastoma Multiforme. Journal of Biomedical Nanotechnology. 12: 347-56. PMID 27305768 DOI: 10.1166/Jbn.2016.2173 |
0.439 |
|
2016 |
Sun L, Joh DY, Al-Zaki A, Stangl M, Murty S, Davis JJ, Baumann BC, Alonso-Basanta M, Kao GD, Tsourkas A, Dorsey JF. Theranostic application of mixed gold and superparamagnetic iron oxide nanoparticle micelles in glioblastoma multiforme Journal of Biomedical Nanotechnology. 12: 347-356. DOI: 10.1166/jbn.2016.2173 |
0.331 |
|
2015 |
Chang E, Pohling C, Natarajan A, Witney TH, Kaur J, Xu L, Gowrishankar G, L D'Souza A, Murty S, Schick S, Chen L, Wu N, Khaw P, Mischel P, Abbasi T, et al. AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models. Journal of Neuro-Oncology. PMID 26650066 DOI: 10.1007/S11060-015-1972-1 |
0.755 |
|
2014 |
Murty S, Gilliland T, Qiao P, Tabtieng T, Higbee E, Al Zaki A, Puré E, Tsourkas A. Nanoparticles functionalized with collagenase exhibit improved tumor accumulation in a murine xenograft model. Particle & Particle Systems Characterization : Measurement and Description of Particle Properties and Behavior in Powders and Other Disperse Systems. 31: 1307-1312. PMID 26380538 DOI: 10.1002/Ppsc.201400169 |
0.367 |
|
2013 |
Sun L, Joh D, Stangl M, Al-Zaki A, Murty S, Alonso-Basanta M, Kao G, Dorsey J, Tsourkas A. Selective Targeting of Brain Tumors With Nanoparticle-induced Radiosensitization and Contrast Enhancement. Practical Radiation Oncology. 3: S19-20. PMID 24674504 DOI: 10.1016/J.Prro.2013.01.067 |
0.327 |
|
2013 |
Joh DY, Kao GD, Murty S, Stangl M, Sun L, Al Zaki A, Xu X, Hahn SM, Tsourkas A, Dorsey JF. Theranostic gold nanoparticles modified for durable systemic circulation effectively and safely enhance the radiation therapy of human sarcoma cells and tumors. Translational Oncology. 6: 722-31. PMID 24466375 DOI: 10.1593/Tlo.13433 |
0.427 |
|
2013 |
Joh DY, Sun L, Stangl M, Al Zaki A, Murty S, Santoiemma PP, Davis JJ, Baumann BC, Alonso-Basanta M, Bhang D, Kao GD, Tsourkas A, Dorsey JF. Selective targeting of brain tumors with gold nanoparticle-induced radiosensitization. Plos One. 8: e62425. PMID 23638079 DOI: 10.1371/Journal.Pone.0062425 |
0.411 |
|
2012 |
Joh D, Kao G, Al Zaki A, Murty S, Tsourkas A, Dorsey J. A Novel ‘Theranostic’ Approach? Polymer-coated Gold Nanoparticles Show Durable Systemic Circulation, Are Readily Imaged, and Radiosensitize Human Cancer Cells and Tumors International Journal of Radiation Oncology*Biology*Physics. 84: S874. DOI: 10.1016/J.Ijrobp.2012.07.2338 |
0.371 |
|
Show low-probability matches. |